Search - tctmd.com

Displaying 401 - 420 of 432

Sort: Relevancy | Date

News Conference News EuroPCR 2013

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Jason Kahn

May 21, 2013

Presentation TCT 2013

Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

Presenter: Stefan Verheye, Mark Webster, James Stewart, Alexandre Abizaid, RICARDO COSTA, Jose Costa Jr, John Yan, vinayak bhat, lynn morrison, Sara Toyloy, John Ormiston

January 31, 2013

News Daily News

ZEN Published: Pelvic Artery Stenting Helps Treat Erectile Dysfunction in Some

November 27, 2012

Presentation TCT 2012

TCT-563: Multicenter First-in-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

Presenter: Stefan Verheye

October 23, 2012

Presentation TCT 2012

TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable...

Presenter: Michael Haude

October 23, 2012

Presentation TCT 2012

TCT-37. Five-year Clinical Outcomes and Non-invasive Angiographic Imaging Results With Functional Assessment After Bioresorbable Everolimus-eluting Scaffold Implantation in...

Presenter: Yoshinobu Onuma

October 23, 2012

Presentation TCT 2012

ABSORB (Abbott Vascular) Program to Date: Integrated Insights from Multimodality Imaging

Presenter: Patrick Serruys

October 23, 2012

News Conference News ESC 2012

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Caitlin E. Cox

August 29, 2012

News Daily News

Los SLF Revelan Más Neoaterosclerosis que los SMD al cabo de 4 Años

L.A. McKeown

July 05, 2012

News Daily News

DES Show More Neoatherosclerosis Than BMS Over 4 Years

L.A. McKeown

July 05, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Conference News EuroPCR 2012

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

CIBELES: Xience Stands Up to Cypher for CTO PCI

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

Strong Showing for Bioabsorbable-Scaffold DES

Caitlin E. Cox

May 16, 2012

Presentation GI2 2012

Focus on In-Stent Restenosis: Imaging to Guide the Best Treatment

Presenter: Jose Ribamar Costa

April 11, 2012

Presentation TCT 2012

Quantitative multi-modality imaging analysis of a fully bioresorbable scaffold: a head-to-head comparison between QCA, IVUS and OCT

Presenter: Juan Luis Guti?rrez-Chico, Patrick W. Serruys, Chrysafios Girasis, Yoshinobu Onuma, Salvatore Brugaletta, H?ctor Manuel Garc?a-Garc?a, Evelyn Regar

January 03, 2012

Presentation TCT 2012

Comparison by Optical Frequency-Domain Imaging of Paclitaxel-Eluting Stents and Everolimus-Eluting Stents Implanted in One Coronary Artery in One Procedure. A 12 Months Follow...

Presenter: Jose M. De la Torre Hernandez, Dae-Hyun Lee, Tamara Garcia Camarero, Piedad Lerena, Gonzalo Martin Gorria, Fermin Sainz Laso, Javier Zueco

January 03, 2012

News Daily News

Stenting, Surgery Achieve Good Hemodynamic Outcomes in Native Aortic Coarctation

Jason Kahn

December 04, 2011

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

Advertisement

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

ZEN Published: Pelvic Artery Stenting Helps Treat Erectile Dysfunction in Some

TCT-563: Multicenter First-in-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable...

TCT-37. Five-year Clinical Outcomes and Non-invasive Angiographic Imaging Results With Functional Assessment After Bioresorbable Everolimus-eluting Scaffold Implantation in...

ABSORB (Abbott Vascular) Program to Date: Integrated Insights from Multimodality Imaging

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Los SLF Revelan Más Neoaterosclerosis que los SMD al cabo de 4 Años

DES Show More Neoatherosclerosis Than BMS Over 4 Years

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

CIBELES: Xience Stands Up to Cypher for CTO PCI

Strong Showing for Bioabsorbable-Scaffold DES

Focus on In-Stent Restenosis: Imaging to Guide the Best Treatment

Quantitative multi-modality imaging analysis of a fully bioresorbable scaffold: a head-to-head comparison between QCA, IVUS and OCT

Comparison by Optical Frequency-Domain Imaging of Paclitaxel-Eluting Stents and Everolimus-Eluting Stents Implanted in One Coronary Artery in One Procedure. A 12 Months Follow...

Stenting, Surgery Achieve Good Hemodynamic Outcomes in Native Aortic Coarctation

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content